Company: MDCXW
Filing Date: 2025-05-30
Form Type: 424B4
Source: 0001062993-25-010548
Chunk: 246

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-30
Form: 424B4
Chunk 246
---
 |
| Current assets:                     |   |                   |     |   |         |     |   |         |     |   |           |
| Money market funds                  | $ |         2,587,501 |     | $ | -       |     | $ | -       |     | $ | 2,587,501 |
| Total assets measured at fair value | $ |         2,587,501 |     | $ | -       |     | $ | -       |     | $ | 2,587,501 |
|                                     |   | December 31, 2024 |     |   |         |     |   |         |     |   |           |
|                                     |   |           Level 1 |     |   | Level 2 |     |   | Level 3 |     |   |     Total |
| Current assets:                     |   |                   |     |   |         |     |   |         |     |   |           |
| Money market funds                  | $ |         4,164,323 |     | $ | -       |     | $ | -       |     | $ | 4,164,323 |
| Total assets measured at fair value | $ |         4,164,323 |     | $ | -       |     | $ | -       |     | $ | 4,164,323 |

The Company's cash equivalents are classified as Level 1. The fair value of the Company's cash and cash equivalents is determined based on market pricing that is both objective and publicly available. The Company did not reclassify any investments between levels in the fair value hierarchy during the periods presented. As of March 31, 2025 and December 31, 2024, the carrying amounts of the Company's other financial instruments, which include cash, accounts payable, and accrued expenses, approximate fair values because of their short-term maturities.

<div align='center'>F-39</div>

10. Commitment and contingencies

Commitments

As of March 31, 2025, the Company had no long-term commitments.

Contingencies

In the ordinary course of business, from time to time, the Company may be involved in various claims related to operations, rights, commercial, employment or other claims. Although such matters cannot be predicted with certainty, management does not consider the Company's exposure to such claims to be material to these consolidated financial statements.

11. Segment reporting

The Company manages